KEY TAKE AWAYS

• To define and intensively analyze the global ophthalmology devices & drugs market.
• To identify and assess the market with respect to all ophthalmic diagnostic & surgical devices, diseases, drugs and overall services currently available in the market.
• To analyze comprehensively each of the market segmentation with respect to market drivers, restraints and opportunities that is impacting the market revenues and trend.
• To quantify and evaluate the market revenues for each of the micro markets with respect to products, applications and services revenues attributed to respective geographies (North America, Europe, Asia and Rest of the World).
• To analyze and comprehend the core competency of the market players by profiling the companies with respect to their product offering, revenues, target market, pricing, pipeline products, patents and recent developments.
• To understand the competitive scenario by tracking an indicative strategy trend such as mergers & acquisitions, alliances, joint ventures etc. in the industry among the top market players.

MARKETS COVERED

A considerable increase in the incidence and prevalence of eye related disorder among aging population has been key driver of the global ophthalmologist devices and drugs market. With the rising population of the baby boomer diseases such as presbyopia, macular degeneration, and diabetic retinopathy have positively impacted the growth of the ophthalmology devices and drugs market. .Minimally invasive and less painful diagnosis and treatment has been boosting the market growth for IOL (Intraocular lenses) implantation and LASER treatment worldwide. Technology advancement, rising innovations and reimbursement support for vision products and procedures are also adding an impetus to the ophthalmology market growth globally.

Globally the ophthalmology market is primarily driven by age- and lifestyle-related diseases like macular degeneration and glaucoma, affecting 1 out of 200 people. Increasing incidence of type 2 diabetes will boost the chances of diabetic retinopathy globally. A rising number of the experienced ophthalmologists and physicians are contributing to the market growth for surgical procedures. Ophthalmic drugs and pharmaceuticals market is currently becoming an attractive segment with numerous patients seeking for painless diagnostic and treatment methods, thereby boosting the market revenues.

This market report will enable strategic understanding on the ophthalmology devices & drugs market. Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles.

SUMMARY TABLE

Key summary tables and description

MARKET OVERVIEW

• Extensive market segmentation of global Ophthalmology devices & drugs market.
• Market penetration model and top down approach for determining the market revenues for each of the markets by products and geography. 
• Further assessment of the market with respect to competitive landscape/ competitive products and pipeline products

APPENDICES

PATENTS HISTORY AND ANALYSIS

Dummy tables

Summary table

SAMPLE TABLES

Global Opthalmology Devices & drugs market: Opthalmic Devices Market

Global Opthalmology Devices & drugs market: Treatment Based & Surgical Equipments

Global Opthalmology Devices & drugs market: diagnostic Devices

Global Opthalmology Devices & drugs market: procedures market

Global Opthalmology Devices & drugs market: diseases market

Global Opthalmology Devices & drugs market: opthalmology drugs and Pharmaceuticals market

Global Opthalmology Devices & drugs market: Services Market

TABLE OF CONTENT

1. Introduction
   1.1. KEY TAKE AWAYS
   1.2. Report description
   1.3. Markets Covered
   1.4. STAKEHOLDERS
2. Summary
3. Market Overview
4. Ophthalmic devices market
   4.1. Ophthalmic devices market –Surgical Equipments
        4.1.1. Microincission
               4.1.1.1. Instruments
                        4.1.1.1.1. Intraocular manipulators
                        4.1.1.1.2. Forceps (posterior segment use)
                        4.1.1.1.3. Phacoemulsification machines
                        4.1.1.1.4. Others
               4.1.1.2. Intraocular Lenses (IOL)
                        4.1.1.2.1. Hydrophobic Acrylic Intraocular Lenses
                        4.1.1.2.2. Silicone Intraocular Lenses
                        4.1.1.2.3. PMMA Intraocular Lenses
                        4.1.1.2.4. Hydrophilic Acrylic Lenses
               4.1.1.3. Viscoelastics
               4.1.1.4. Phacoemulsification Consoles
               4.1.1.5. Ophthalmic LASERS
                        4.1.1.5.1. Photocoagulation Laser
                                   4.1.1.5.1.1. 532 nm Wavelength Laser
                                   4.1.1.5.1.2. Multiwavelength Laser
                                   4.1.1.5.1.3. 810 nm Laser
                        4.1.1.5.2. Photodisruption (YAG) Laser
                        4.1.1.5.3. SLT Laser Market
                        4.1.1.5.4. Photodynamic Laser
                        4.1.1.5.5. Therapeutic Ophthalmic Lasers
               4.1.1.6. Vitrectomy Consoles
               4.1.1.7. Glaucoma Shunts
               4.1.1.8. Implantable Lenses
               4.1.1.9. Photorefractive Surgery
               4.1.1.10. Ophthalmic Surgical Microscopes
               4.1.1.11. Other Surgical devices
                        4.1.1.11.1. Keratometers
                        4.1.1.11.2. Phaco Splitter
                        4.1.1.11.3. Scalpel
                        4.1.1.11.4. Ophthalmodynamometer
                        4.1.1.11.5. Ophthalmodiaphanoscope
                        4.1.1.11.6. Endo illuminators
                        4.1.1.11.7. Speculums Blade Handles
                        4.1.1.11.8. Sterilization Trays
   4.2. Ophthalmic devices market – Treatment based Devices
        4.2.1. Ophthalmoscopes
        4.2.2. Ophthalmic lens
        4.2.3. Rigid Gas Permeable Contact Lenses
        4.2.4. Contact lenses
               4.2.4.1. By material
                        4.2.4.1.1. Hard Lenses
                        4.2.4.1.2. Soft Lenses
                        4.2.4.1.3. GP lenses
               4.2.4.2. By Disposability
                        4.2.4.2.1. Daily Disposable
                        4.2.4.2.2. Continuous Wear
                        4.2.4.2.3. Planned Replacement
               4.2.4.3. By Wearing time
                        4.2.4.3.1. Daily wear
                        4.2.4.3.2. Extended wear
               4.2.4.4. By Design
                        4.2.4.4.1. Spherical
                        4.2.4.4.2. Bifocal
                        4.2.4.4.3. Orthokeratology
                        4.2.4.4.4. Toric
               4.2.4.5. By Features
                        4.2.4.5.1. Colored lenses
                        4.2.4.5.2. Special Feature lenses
                        4.2.4.5.3. Prosthetic Lenses
                        4.2.4.5.4. Custom Lenses
                        4.2.4.5.5. UV-Inhibiting Lenses
                        4.2.4.5.6. Hybrid Lenses
5. Ophthalmic device market – Diagnostic devices market
   5.1. Perimeters
   5.2. Refractometer
   5.3. Tear solution
   5.4. Slit Lamps
        5.4.1. Standard Slit Lamp
        5.4.2. Handheld Slit Lamp
   5.5. Tonometers
        5.5.1. Noncontact Tonometer
        5.5.2. Handheld Tonometer
        5.5.3. Contact Tonometer
   5.6. Fundus Cameras and Fundus Reflectometers
        5.6.1. Nonmydriatic Fundus Camera
        5.6.2. Mydriatic Fundus Camera
   5.7. Lens Meters
   5.8. Ophthalmoscopes
        5.8.1. Direct ophthalmoscope
        5.8.2. Indirect ophthalmoscope
   5.9. Ultrasound Equipment
        5.9.1. Pachymeter
        5.9.2. A-Scan
        5.9.3. A/B-Scan
        5.9.4. B-Scan
        5.9.5. High-Frequency Ultrasound
   5.10. Corneal Topography Systems
   5.11. Diagnostic Imaging Systems (Diabetes Retinopathy & Others)
        5.11.1. Optical coherence tomography
        5.11.2. Digital Retinal Screening Programs
        5.11.3. Slit Lamp Biomicroscopy
   5.12. Autorefractor and keratometer
   5.13. Iris hooks  
   5.14. Capsular tension rings
   5.15. Pupil dilators
   5.16. Ocular esthesiometer
6. Ophthalmic device market – Procedures market
   6.1. Cataract Procedure
        6.1.1. Phacoemulsification
        6.1.2. IOL Implantation
        6.1.3. Posterior Capsular Opacification Removal
        6.1.4. Linear Extraction
        6.1.5. Intracapsular Extraction
        6.1.6. Extracapsular Extraction
        6.1.7. Micro-incision
               6.1.7.1. Low – ultrasound MICS
               6.1.7.2. Laser MICS
   6.2. Laser Eye Procedures
        6.2.1. Laser in-situ Keratomileusis (LASIK)
               6.2.1.1. Epi-LASIK
               6.2.1.2. Custom Wavefront  LASIK
               6.2.1.3. IntraLase "Bladeless" LASIK
               6.2.1.4. Mechanical bladed LASIK
               6.2.1.5. PresbyLASIK
        6.2.2. Photorefractive Keratectomy (PRK)
               6.2.2.1. LASEK (Laser Epithelial Keratomileusis)
               6.2.2.2. Epi-LASEK
        6.2.3. Laser Thermal Keratoplasty (LTK)   
   6.3. Corneal Procedures / Refractive Surgery
        6.3.1. Cauterization
        6.3.2. Pterygium Excision   
        6.3.3. Corneal Transplantation (Keratoplasty)   
        6.3.4. Phototherapeutic Keratectomy (PTK)   
        6.3.5. Radial Keratotomy (RK)
        6.3.6. Femtosecond Laser
        6.3.7. Other Alternative Refractive Procedures
        6.3.8. PAI (Photoablative Inlay)
        6.3.9. Intrastromal Corneal Ring (Intacs)
        6.3.10. Phakic Intraocular Lenses
        6.3.11. Astigmatic Keratotomy (AK)   
        6.3.12. Conductive Keratoplasty (CK)  
   6.4. Retinal Procedure
        6.4.1. Retinal Detachment Repair
        6.4.2. Macular Hole Surgery
        6.4.3. Diabetes retinopathy
               6.4.3.1. Laser photocoagulation
               6.4.3.2. Panretinal photocoagulation
               6.4.3.3. Intravitreal Triamcinolone acetonide
               6.4.3.4. Vitrectomy
                        6.4.3.4.1. Anterior vitrectomy
                        6.4.3.4.2. Pars plana vitrectomy
        6.4.4. Near-infrared light (NIR)
   6.5. Extraocular Surgical Procedures  
        6.5.1. Eyelid Procedures
        6.5.2. Lacrimal Duct Procedures
        6.5.3. Eye Muscle Procedures 
        6.5.4. Orbital Procedures 
7. Ophthalmology Drugs & Pharmaceuticals market
   7.1. OTC Drugs
        7.1.1. Ocular Nutrition (Eye Vitamins)
               7.1.1.1. Capsules
               7.1.1.2. Gels
               7.1.1.3. Tablets
               7.1.1.4. Solution
        7.1.2. Eye Drops
               7.1.2.1. Antihistamine eye drops
               7.1.2.2. Lubricant Eye drops
        7.1.3. Eye Ointments
        7.1.4. Eye Solutions
   7.2. Treatment based Drugs
        7.2.1. Dry Eye Drug
               7.2.1.1. Restasis (US)
               7.2.1.2. Hyalein  (China & Japan)
        7.2.2. Retinol Disorder
               7.2.2.1. Lucentis
               7.2.2.2. Visudyne
               7.2.2.3. Bevacizumab
        7.2.3. Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs market
               7.2.3.1. Patanol/Opatanol/Pataday
               7.2.3.2. TobraDex
               7.2.3.3. Vigamox/Vegamox
        7.2.4. Anti-Glaucoma Market
               7.2.4.1. Prostaglandin
               7.2.4.2. Xalatan/Xalacom
               7.2.4.3. Cosopt/Trusopt
               7.2.4.4. Travatan/Travatan Z/DuoTrav
         Lumigan/Ganfort
               7.2.4.5. Alphagan/Combigan
               7.2.4.6. Azopt   
   7.3. Ocular Anesthetics
        7.3.1. Ocular Muscle Spasm Treatments   
        7.3.2. Pain Management Treatments 
        7.3.3. Vasoconstrictors
        7.3.4. Other Treatments
8. Ophthalmology Services Market
   8.1. Diagnostic Retail Optical services
        8.1.1. Retail optician
               8.1.1.1. Lens
               8.1.1.2. Spectacles
   8.2. Hospital Services
        8.2.1. Consulting Services
        8.2.2. Surgical procedures
               8.2.2.1. Laser Treatment
               8.2.2.2. Implantation
   8.3. Other Treatment and Diagnostic Services
Total Ophthalmic Market by Diseases and Disorders
   8.4. Ocular Inflammatory Disorders
               8.4.1.1. Chalazion
               8.4.1.2. Uvetitis
               8.4.1.3. Anterior Uveitis
               8.4.1.4. Intermediate Uveitis
               8.4.1.5. Posterior Uveitis
        8.4.2. Ocular Infections
               8.4.2.1. Hordeolum
   8.5. External Hordeolum - Small Yellowish Spot
   8.6. Internal Hordeolum
        8.6.1. Beharitis
        8.6.2. Conjunctivitis
               8.6.2.1. Bacterial
               8.6.2.2. Viral
        8.6.3. Epidemic Keratoconjunctivitis
        8.6.4. Keratitis
               8.6.4.1. Herpes Simplex Keratitis
               8.6.4.2. Bacterial Keratitis
               8.6.4.3. Fungal Keratitis
               8.6.4.4. Acanthamoeba Keratitis
   8.7. Ocular Allergies
        8.7.1. Seasonal & Perennial Allergic Conjunctivitis
               8.7.1.1. Seasonal Allergic Conjunctivitis - Manifestation of Hayfever
               8.7.1.2. Perennial Allergic Conjunctivitis: Persistant
        8.7.2. Giant Papillary Conjunctivitis
        8.7.3. Vernal Keratoconjunctivitis
        8.7.4. Atopic Keratoconjunctivitis
   8.8. Age Related Macular Degeneration (AMD)
        8.8.1. Dry AMD
        8.8.2. Wet AMD
   8.9. Cataract
   8.10. Glaucoma
        8.10.1. Primary Open Angle Glaucoma
        8.10.2. Closed Angle Glaucoma
        8.10.3. Secondary Glaucoma
        8.10.4. Normal Tension Glaucoma (NTG)
        8.10.5. Pigmentary Glaucoma
   8.11. Retinal diseases
        8.11.1. Diabetic retinopathy
        8.11.2. Retinitis pigmentosa
        8.11.3. Retinopathy of prematurity
        8.11.4. Giant Retinal Tear (GRT)
   8.12. Other disorders
        8.12.1. Myopia
        8.12.2. Hypermetropia
        8.12.3. Antigmatism
9. Key Industry Participants
   9.1. Abbott medical optics
   9.2. Acadia
   9.3. Acuity Pharmaceuticals
   9.4. Advanced Vision Research
   9.5. Akorn
   9.6. Alcon
   9.7. Alimera Sciences
   9.8. Allergan
   9.9. Alza
   9.10. A.R.C. Laser Corp
   9.11. Asah Glass
   9.12. ASTA
   9.13. AstraZeneca
   9.14. Aventis
   9.15. Banyu Pharmaceuticals
   9.16. Barr
   9.17. Bausch & Lomb
   9.18. Baxter
   9.19. Bio-Logic Aqua Technology
   9.20. BMS
   9.21. Carl Zeiss Meditech 
   9.22. Celegene
   9.23. Celltech
   9.24. Chauvin
   9.25. CIBA Vision
   9.26. Daiichi Nippon
   9.27. Dista
   9.28. Eyetech Pharmaceuticals
   9.29. Fujisawa
   9.30. Genera
   9.31. Genetech
   9.32. Genvec
   9.33. Gilead Sciences
   9.34. Goldshield
   9.35. GSK
   9.36. Haag Stereit
   9.37. Inflazyme Pharmaceuticals
   9.38. Insite
   9.39. Inspire Pharmaceuticals
   9.40. Isis Pharmaceuticals
   9.41. ISTA
   9.42. Ixis
   9.43. Janseen Pharmaceuticals
   9.44. Karo Bio SIFI
   9.45. LaserSight Technologies, Inc
   9.46. Medimmune
   9.47. Merck
   9.48. Miravant Medical Technology
   9.49. Monarch
   9.50. Nidek Co., Ltd. 
   9.51. Norvartis
   9.52. Novagali
   9.53. Oculex
   9.54. OcuSoft
   9.55. Orgaeon
   9.56. Orhto-McNeil Pharmaceuticals
   9.57. Othera
   9.58. Oxigene
   9.59. Pfizer
   9.60. Pharmadix
   9.61. Pliva Pharmaceuticals
   9.62. QLT
   9.63. Restan
   9.64. Roche
   9.65. Sankyo
   9.66. Santen
   9.67. Scherag
   9.68. Schering-Plough
   9.69. Senju
   9.70. Sucampo Pharmaceuticals  
   9.71. Topcon
   9.72. Vista Scientific
   9.73. Welch Allyn    
   9.74. Wyeth

Please fill in the form below to receive a free copy of the Summary of this Report

Please fill in the form below to receive a free copy of PDF Brochure.